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While the deadline for the General 
Data Protection Regulation (‘GDPR’ 
- Regulation 2016/679) is looming in 
all EU Member States, the European 
eHealth sector is expecting new 
technological upheavals, involving 
both private and institutional players, 
which should accelerate growth 
and trigger true innovation.
The EU-funded My Health My Data 
(‘MHMD’) project stands at the very 
centre of this change and aims to 
revolutionise healthcare from within, 
by making patients and individuals 
more aware of the real value of their 
health data, by means of a secure and 
distributed technological ecosystem. 
The very essence of MHMD is built 
on one of the main pillars of EU data 
protection law, the principle of habeas 
data, which grants individuals the right 
to take back control of their personal 
data, with crucial consequences from a 
legal, social and economic point of view.
The project has been conceived, from 
the outset, with a view to changing the 
way sensitive data are shared, making 
use of an innovative distributed model 
of smart contracts that enforces consent 
mechanisms and peer-to-peer data 
transactions between public and private 
healthcare providers and patients. The 
ultimate goal is to transform the data 
access and control rights that individuals 
are vested with under applicable law 
into a straightforward innovation enabler 
for both the public and private clinical 
sectors, in order to foster medical and 
scientific research while setting novel 
security benchmarks, especially in 
light of the forthcoming GDPR. The 
current state of the art of EU digital 
healthcare shows a myriad of isolated, 
locally hosted and unsafe medical data 
repositories which are often subject to 
violations and data breaches, caused 
by both internal issues and outside 
threats (i.e. WannaCry and the like).
In this context, patients and individuals 
are understandably discouraged from 
giving their consent to the processing of 
their data for further medical research 
purposes, as in most cases they are not 
(put) in the position of having a clear 
understanding of who is using their data, 
for what purposes and, most importantly, 
what measures have been implemented 
to safeguard this information.
The MHMD project aims to change 
this scenario, enhancing the value 
of data subjects’ consent and 
granting them effective and ongoing 
control of their data flows through 
personal accounts operating on a 
dynamic multi-platform basis.
By gathering clinical records from 
all medical stakeholders (hospitals, 
research centres and businesses) and 
wellness data via a specific mobile 
app, featuring privacy-by-design, 
while boosting patients’ continuous 
monitoring of their data flows, the 
project reflects the switch of paradigm 
provided by the disintermediation of 
healthcare services through advanced 
technology and big data analytics.
Patient related data will be classified 
based on their nature and scientific 
value, so that the most suitable and 
robust de-identification and encryption 
measures can be applied, which still 
allows advanced knowledge discovery 
through analytics and deep learning 
applications running on a growing amount 
of anonymised or pseudonymised data.
To achieve such goals whilst complying 
with the GDPR, the project has been built 
on four main operational pillars, aimed 
at ensuring that all pivotal requirements 
of the regulation will be properly 
implemented: dynamic consent, personal 
data accounts (‘PDAs’), smart contracts 
and encryption techniques, all embedded 
in a blockchain-based network.
Within this architecture, information 
relating to the distributed storage of 
health data are trimmed in a hash-
based language code ensuring 
the highest security standards.
The most advanced encryption 
techniques (some of which are currently 
being examined at international level) 
will be deployed throughout the entire 
infrastructure, such as secure multi-
party computation, homomorphic 
encryption and PEP - polymorphic 
encryption and pseudonymisation - in 
order to secure all the information 
running on the blockchain.
Data flows will be continuously validated 
by the entire network of blockchain 
users, avoiding any possibility of 
fraudulent usage, while also reducing the 
risk of data breaches or losses. Smart 
contracts will also play a crucial role in 
the project, as they are the best tool, on 
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account of their self-executing nature, 
for automatically regulating data flows 
between data subjects and stakeholders, 
in such a way as to create a pan-EU 
(and then, hopefully, an international) 
network of healthcare data for research 
purposes. As in real life transactions, 
rights and obligations built into the smart 
contracts will be binding among all the 
parties operating within the MHMD 
environment and connected to each 
data subject’s true expression of will.
Individuals will be put in a position 
to modulate, by means of a granular 
consent interface embedded within 
their personal data account, the permits 
- then enforced by smart contracts 
- for accessing and processing their 
data by each stakeholder, whether a 
research centre, a healthcare facility, 
a business or other organisation.
In this way, patients will finally be able 
to fully leverage the value of their 
personal data, for instance, turning to 
different healthcare professionals for 
second opinions in a much smoother 
way, or finding patients with similar 
conditions and contacting them when 
they receive permission; similarly 
they may decide to share their health 
information on a monthly basis with their 
local hospital and not with their personal 
physician, or provide information for 
research purposes to biomedical 
centres and universities, and so on.
A straightforward probative, secure, 
open and decentralised technological 
framework will be created which will 
enable patients to securely share their 
personal and medical information with 
third parties, whilst keeping full and 
ongoing control over any first or further-
compatible processing carried out by 
the various stakeholders joining the 
project, all bound by the strong security 
policies governing the blockchain 
and the relevant data exchanges.
The overall security of the project’s 
multi-modular architecture will be tested 
repeatedly through dedicated self-hacking 
simulations and public hacking challenges, 
performed on synthetic data sets.
Consistent with the novel benchmark 
set by the GDPR, the whole project 
has been designed in such a way as 
to fulfil, also in the light of a specific 
data protection impact assessment, 
the requirements of privacy-by-design 
and by-default. This means, in reality, 
that all measures and safeguards 
will be put in place as necessary to 
ensure the implementation of the key 
principles set forth by the GDPR and, 
particularly to avoid the collection (and 
processing) of personal data which are 
not reasonably essential to achieve 
the intended research purposes.
In addition, the whole distributed 
infrastructure and the processes 
underpinning its functioning are being 
developed by a joint technical/legal 
team, in order to ensure that all the 
rights provided for by the GDPR can 
be easily exercised at any moment by 
the data subjects, as long as (some 
of) these rights are not likely to render 
impossible or seriously impair the 
achievement of the objectives of the 
research (e.g. the right to erasure).
The concrete application of so many 
disruptive technological innovations 
is obviously proving to be more than 
challenging. Nonetheless, thanks to 
in-depth analysis of the current and 
forthcoming regulatory framework 
and the involvement of a wide team 
of multi-disciplinary experts, the 
project - also as a bench mark - is 
increasingly attracting the interest of 
both institutions and market players 
and is already building, step by step, 
a brand new European eHealth and 
biomedical research ecosystem.
Disintermediation of digital personal 
medicine and the Internet of Things 
are in the spotlight, as are distributed 
ledger systems: that is why the MHMD 
intends to bring the discussion to a new 
level, by fostering the use of blockchain 
and patient-centric technologies, 
in order to provide a new basis for 
digital disruption in the scientific 
research and healthcare sector.
Putting individuals in a position to be able 
to exercise full control and leverage over 
their personal and health data is only the 
first step towards the re-thinking of the 
right to habeas data in the digital age.
The ultimate goal of the MHMD 
is to help the development and 
consolidation of the first health 
distributed data marketplace in 
the EU, based on common rules, 
fairness, transparency, robust security 
standards, openness and full and 
substantial interoperability criteria. 
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